Clinical Social Workers in Glenmora, LA Accepting Medicare
1 Clinical Social Workers found. Showing 1 - 1
 Tambra Malone, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1414 7th Avenue, Glenmora, LA 71433 Phone: 318-748-8974 Fax: 318-748-8986 |
News Archive
DSMB authorizes Oxygen Biotherapeutics' next cohort of Oxycyte emulsion study in severe non-penetrating TBI
Oxygen Biotherapeutics, Inc. reported today that the Data Safety Monitoring Board overseeing the company's ongoing Phase II-b trial has, based on the results of the first cohort of patients, authorized the company to move forward with the next cohort of the study. This trial is a randomized, single-dose, placebo-controlled, double-blind, dose-escalation study to evaluate the safety and tolerability of our Oxycyte® emulsion in patients with severe non-penetrating traumatic brain injury.
Serum hormones, bone remodeling markers in bears could help create model for preventing osteoporosis: Study
Bears hibernate all winter, yet when they awaken in the spring, their bones are as strong as ever. Human beings don't hibernate, but their bones do degenerate as they grow older and when they aren't being used. Those who are bedridden for any length of time, even astronauts in the low- or no-gravity conditions of outer space, face the perils of osteoporosis.
Birth control pill safety issues raised
The U.S. Food and Drug Administration (FDA) has announced that it is looking at results from two studies that showed there is a higher risk of blood clots in women taking new birth control pills containing the compound drospirenone. Some brand names include Yaz, Yasmin, Beyaz, Ocella, Loryna, Gianvi, Safyral, Syeda and Zarah.
Sinobiopharma receives certificate for using Gabexate Mesylate as pharmaceutical raw material
Sinobiopharma, Inc. ("Sinobiopharma") (the "Company") is pleased to announce that the Company received a certificate for the use of Gabexate mesylate as a pharmaceutical raw material (Certificate #2009S01805) from the Chinese State Food and Drug Administration ("SFDA").
'Doctor Shopping': Data from California's prescription monitoring program
Research presented at the American Academy of Pain Medicine's 26th Annual Meeting provides early published data analyzing information gathered from California's prescription monitoring program, known as the Controlled Substances Utilization Review and Evaluation System (CURES). The analysis found a two-fold increase in the likelihood of individuals receiving opioids from multiple providers or "doctor shopping" when they were also being simultaneously prescribed a single additional class of a controlled substances, such as benzodiazepines or amphetamines.
› Verified 9 days ago